Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-01-03 @ 6:02 AM
Study NCT ID:
NCT01709760
Status:
UNKNOWN
Last Update Posted:
2018-04-17
First Post:
2012-10-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA
Sponsor:
Mycenax Biotech Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-11
Start Date Type:
None
Primary Completion Date:
2017-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-12
Completion Date Type:
ESTIMATED
First Submit Date:
2012-10-16
First Submit QC Date:
None
Study First Post Date:
2012-10-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-04-13
Last Update Post Date:
2018-04-17
Last Update Post Date Type:
ACTUAL